Get unlimited digital access to $0.99 for 4 weeks.


Look to animals to cure Ebola
Look to animals to cure Ebola

GlaxoSmithKline and Merck will test new Ebola vaccines in West Africa this month. They're racing to cure this disease that causes severe hemorrhagic fever in humans and other mammals. To date, Ebola has claimed more than 8,600 lives and infected more than 20,000 people in Sierra Leone, Liberia and Guinea. These vaccines have shown promise in preliminary safety trials involving animals and could eventually save the lives of thousands of people worldwide. Animal research is vital to the study of disease, and it is the primary reason why scientists have hope that they'll be able to cure Ebola and other emerging infectious diseases. Scientists rely on animal models to learn about...